China Renews List of Devices Exempt From Clinical Trials
This article was originally published in Clinica
China's Food and Drug Administration is inviting feedback on a new batch of medium- and high-risk medical devices that it intends to exempt from having to undergo local clinical trials. The agency's proposal, if adopted, would make it much easier and less costly for companies that want to place these devices on the Chinese market.
Register for our free email digests: